Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
$1.39
-7.5%
$1.65
$1.33
$5.00
$3.64M1.888,493 shs13,151 shs
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$0.63
+13.4%
$0.75
$0.47
$13.98
$1.68M0.8545,360 shs28,435 shs
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.51
-10.7%
$0.47
$0.37
$1.51
$2.51M0.45367,667 shs39,400 shs
NEXGEL, Inc. stock logo
NXGL
NEXGEL
$2.22
-3.1%
$2.44
$1.40
$3.14
$13.83M0.6820,695 shs1,426 shs
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-1.76%+6.22%-14.11%-16.50%-61.92%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
+0.20%-0.42%-32.11%-28.45%-91.14%
Dynatronics Co. stock logo
DYNT
Dynatronics
-2.44%+3.43%+29.54%+12.60%-60.32%
NEXGEL, Inc. stock logo
NXGL
NEXGEL
-1.93%+3.63%-15.68%+2.93%+47.42%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.6376 of 5 stars
3.53.00.00.01.90.00.6
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
0.8419 of 5 stars
3.03.00.00.00.60.00.6
NEXGEL, Inc. stock logo
NXGL
NEXGEL
1.2766 of 5 stars
0.05.00.00.02.53.30.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
3.00
Buy$10.00619.42% Upside
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
2.00
HoldN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
2.00
Hold$3.80639.30% Upside
NEXGEL, Inc. stock logo
NXGL
NEXGEL
N/AN/AN/AN/A

Current Analyst Ratings

Latest DYNT, AEMD, NXGL, and BJDX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/4/2024
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$23.00 ➝ $10.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
$570K6.39N/AN/A$6.56 per share0.21
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$250K6.73N/AN/A$2.34 per share0.27
Dynatronics Co. stock logo
DYNT
Dynatronics
$40.61M0.06N/AN/A$2.19 per share0.23
NEXGEL, Inc. stock logo
NXGL
NEXGEL
$4.09M3.38N/AN/A$0.90 per share2.47

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-$12.03M-$4.99N/AN/AN/AN/A-106.28%-86.60%6/26/2024 (Estimated)
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$9.95M-$9.01N/AN/AN/A-168.38%-122.58%5/8/2024 (Estimated)
Dynatronics Co. stock logo
DYNT
Dynatronics
-$4.97M-$1.38N/AN/A-14.13%-54.88%-16.14%5/9/2024 (Estimated)
NEXGEL, Inc. stock logo
NXGL
NEXGEL
-$3.16M-$0.56N/AN/A-77.19%-49.49%-30.50%5/20/2024 (Estimated)

Latest DYNT, AEMD, NXGL, and BJDX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/1/2024Q4 2023
NEXGEL, Inc. stock logo
NXGL
NEXGEL
N/A-$0.19-$0.19-$0.19N/A$1.08 million
3/28/2024Q4 2023
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$0.68-$1.78-$1.10-$1.78N/AN/A
2/14/2024Q3 2024
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-$1.23-$1.37-$0.14-$1.37N/AN/A
2/7/2024Q2 2024
Dynatronics Co. stock logo
DYNT
Dynatronics
N/A-$0.27-$0.27-$0.27N/A$8.15 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/AN/AN/AN/AN/A
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
NEXGEL, Inc. stock logo
NXGL
NEXGEL
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/A
3.93
3.93
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/A
1.82
1.82
Dynatronics Co. stock logo
DYNT
Dynatronics
0.21
1.41
0.67
NEXGEL, Inc. stock logo
NXGL
NEXGEL
0.10
1.98
1.46

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.99%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
18.47%
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
NEXGEL, Inc. stock logo
NXGL
NEXGEL
2.21%

Insider Ownership

CompanyInsider Ownership
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
4.00%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
47.00%
Dynatronics Co. stock logo
DYNT
Dynatronics
9.10%
NEXGEL, Inc. stock logo
NXGL
NEXGEL
27.15%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
152.62 million2.52 millionOptionable
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
102.69 million1.43 millionNot Optionable
Dynatronics Co. stock logo
DYNT
Dynatronics
1544.88 million4.44 millionNot Optionable
NEXGEL, Inc. stock logo
NXGL
NEXGEL
126.23 million4.54 millionNot Optionable

DYNT, AEMD, NXGL, and BJDX Headlines

SourceHeadline
NEXGEL CEO to Spotlight Company at Planet MicroCap ShowcaseNEXGEL CEO to Spotlight Company at Planet MicroCap Showcase
msn.com - April 21 at 9:11 AM
NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024
finance.yahoo.com - April 18 at 12:36 PM
NEXGEL (NXGL) Price Target Decreased by 14.29% to 6.12NEXGEL (NXGL) Price Target Decreased by 14.29% to 6.12
msn.com - April 17 at 6:30 AM
ABBV Mar 2025 180.000 putABBV Mar 2025 180.000 put
finance.yahoo.com - April 4 at 9:20 PM
NexGel Inc: Sustained Buy Rating Amid Growth and Strategic PositivityNexGel Inc: Sustained Buy Rating Amid Growth and Strategic Positivity
markets.businessinsider.com - April 3 at 1:20 PM
NEXGELs Engineered Growth: A Triumph in Operational Efficiency and Strategic PartnershipsNEXGEL's Engineered Growth: A Triumph in Operational Efficiency and Strategic Partnerships
msn.com - April 3 at 8:19 AM
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-YearNEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
globenewswire.com - April 1 at 7:50 AM
NEXGEL Announces Q4 and Full-Year 2023 Earnings Call DateNEXGEL Announces Q4 and Full-Year 2023 Earnings Call Date
msn.com - March 31 at 8:01 PM
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to HolidayNEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday
globenewswire.com - March 27 at 9:00 AM
NEXGEL Sets Date for Q4 and Full-Year 2023 Earnings RevealNEXGEL Sets Date for Q4 and Full-Year 2023 Earnings Reveal
msn.com - March 25 at 4:17 AM
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28thNEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th
globenewswire.com - March 21 at 9:00 AM
NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12thNEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th
globenewswire.com - March 4 at 8:30 AM
NEXGEL (NXGL) Price Target Increased by 16.67% to 7.14NEXGEL (NXGL) Price Target Increased by 16.67% to 7.14
msn.com - February 24 at 5:59 PM
NEXGEL Raises Capital, Strengthens Balance Sheet Amid Growth OpportunitiesNEXGEL Raises Capital, Strengthens Balance Sheet Amid Growth Opportunities
msn.com - February 23 at 6:49 AM
NEXGEL Announces $975,000 Registered Direct Offering Led by InsidersNEXGEL Announces $975,000 Registered Direct Offering Led by Insiders
finance.yahoo.com - February 21 at 9:06 PM
NEXGEL to Present at The Microcap Conference, January 30th through February 1stNEXGEL to Present at The Microcap Conference, January 30th through February 1st
finance.yahoo.com - January 18 at 9:18 AM
NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024
finance.yahoo.com - January 9 at 12:43 PM
NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North AmericaNEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America
finance.yahoo.com - December 11 at 1:03 PM
Analysts Are Bullish on Top Healthcare Stocks: Veeva Systems (VEEV), Neurocrine (NBIX)Analysts Are Bullish on Top Healthcare Stocks: Veeva Systems (VEEV), Neurocrine (NBIX)
markets.businessinsider.com - December 7 at 10:37 PM
NEXGEL Acquires Kenkoderm Psoriasis Skincare LineNEXGEL Acquires Kenkoderm Psoriasis Skincare Line
finance.yahoo.com - December 5 at 12:41 PM
Nexgel (NXGL) Price Target Increased by 20.00% to 6.12Nexgel (NXGL) Price Target Increased by 20.00% to 6.12
msn.com - November 27 at 6:36 PM
NEXGEL, Inc. (NASDAQ:NXGL): When Will It Breakeven?NEXGEL, Inc. (NASDAQ:NXGL): When Will It Breakeven?
finance.yahoo.com - November 26 at 1:27 PM
NEXGEL, Inc. (NASDAQ:NXGL) Q3 2023 Earnings Call TranscriptNEXGEL, Inc. (NASDAQ:NXGL) Q3 2023 Earnings Call Transcript
insidermonkey.com - November 20 at 12:03 PM
NEXGEL GAAP EPS of -$0.10 beats by $0.02, revenue of $1.2M in-lineNEXGEL GAAP EPS of -$0.10 beats by $0.02, revenue of $1.2M in-line
msn.com - November 13 at 9:08 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aethlon Medical logo

Aethlon Medical

NASDAQ:AEMD
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.
Bluejay Diagnostics logo

Bluejay Diagnostics

NASDAQ:BJDX
Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Dynatronics logo

Dynatronics

NASDAQ:DYNT
Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.
NEXGEL logo

NEXGEL

NASDAQ:NXGL
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.